Laboratory Investigation of Out-of-Specification Results
This training will build the foundation for the implementation of adequate procedures and provide a review of existing procedures and practices, The discussion will be based on the FDA guidance on handling OOS laboratory results, also this will provide a clear process for compliant laboratory OOS investigations.
Wednesday, April 28, 2021
10:00 AM PDT | 01:00 PM EDT
More Trainings by this Expert
Product Id : 503688
Live: One Dial-in One Attendee
Corporate Live: Any number of participants
Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
The objective of this webinar is to develop an understanding of how a compliant laboratory handles the investigation of out-of-specification (OOS) test results and how the laboratory interfaces with other units through the laboratory investigation process. The discussion will be based on the FDA guidance on handling OOS laboratory results.
This live webinar training will provide a clear process for compliant laboratory OOS investigations.
Why should you Attend: The FDA is inspecting laboratory operations very closely, with an emphasis on how the laboratory investigates Out-of-specification and out-of-tolerance observation investigations. All Laboratory and Quality Assurance management, analysts and reviewers should be aware of the FDA expectations for procedures that define a complete, scientifically sound investigation of each out-of-specification and out-of-trend laboratory observation and evidence that laboratory personnel are following the procedures. This training will build the foundation for the implementation of adequate procedures and provide a review of existing procedures and practices.
Areas Covered in the Session:
Who Will Benefit:
- Why the regulators are concerned about the handling of OOS investigations
- The FDA model for handling OOS investigations
- Commonly accepted terminology such as repeat testing and retesting
- How the laboratory can meet regulatory expectations for OOS investigations
- The interaction between the laboratory and other units in the organization
- Laboratory Managers
- Laboratory Supervisors
- Laboratory Analysts
- Quality Assurance Managers
- Quality Assurance Record Reviewers
John (Jerry) Lanese is an independent consultant with a focus on Laboratory Controls, Quality Systems and the components of an effective Quality System as they apply to the pharmaceutical and medical device industries and their suppliers to those industries.
He received a BA and MS from Middlebury College and a Ph.D. in Analytical Chemistry from the University of Michigan. Dr. Lanese focuses on the development of Quality Systems and trains extensively on related topics. He lectures throughout the world and presents training in all formats (lectures, seminars and webinars) on a variety of topics related to Quality Systems, GMPs, APIs, training, laboratory operations, calibration, change control, deviations and product reviews for clients and seminar, webinar and conference providers.
Jerry is a member of the Editorial Board of the Journal of GXP Compliance and co-edits a continuing column, "GXP Talk" in the Journal of GXP Compliance.